Estrogens are essential hormones for the regulation of fertility. Cellular responses to estrogens are mediated by estrogen receptor a (ESR1) and estrogen receptor b (ESR2). In mouse and rat models, disruption of Esr1 causes infertility in both males and females. However, the role of ESR2 in reproductive function remains undecided because of a wide variation in phenotypic observations among Esr2-mutant mouse strains. Regulatory pathways independent of ESR2 binding to its cognate DNA response element have also been implicated in ESR2 signaling. To clarify the regulatory roles of ESR2, we generated two mutant rat models: one with a null mutation (exon 3 deletion, Esr2 DE3 ) and the other with an inframe deletion selectively disrupting the DNA binding domain (exon 4 deletion, Esr2 DE4 ). In both models, we observed that ESR2-mutant males were fertile. ESR2-mutant females exhibited regular estrous cycles and could be inseminated by wild-type (WT) males but did not become pregnant or pseudopregnant. Esr2-mutant ovaries were small and differed from WT ovaries by their absence of corpora lutea, despite the presence of follicles at various stages of development. Esr2 DE3 -and Esr2
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Estrogens are essential hormones for the regulation of fertility. Cellular responses to estrogens are mediated by estrogen receptor a (ESR1) and estrogen receptor b (ESR2). In mouse and rat models, disruption of Esr1 causes infertility in both males and females. However, the role of ESR2 in reproductive function remains undecided because of a wide variation in phenotypic observations among Esr2-mutant mouse strains. Regulatory pathways independent of ESR2 binding to its cognate DNA response element have also been implicated in ESR2 signaling. To clarify the regulatory roles of ESR2, we generated two mutant rat models: one with a null mutation (exon 3 deletion, Esr2 DE3 ) and the other with an inframe deletion selectively disrupting the DNA binding domain (exon 4 deletion, Esr2 DE4 ). In both models, we observed that ESR2-mutant males were fertile. ESR2-mutant females exhibited regular estrous cycles and could be inseminated by wild-type (WT) males but did not become pregnant or pseudopregnant. Esr2-mutant ovaries were small and differed from WT ovaries by their absence of corpora lutea, despite the presence of follicles at various stages of development. Esr2 DE3 -and Esr2
DE4
-mutant females exhibited attenuated preovulatory gonadotropin surges and did not ovulate in response to a gonadotropin regimen effective in WT rats. Similarities of reproductive deficits in Esr2 DE3 and Esr2 DE4 mutants suggest that DNA binding-dependent transcriptional function of ESR2 is critical for preovulatory follicle maturation and ovulation. Overall, the findings indicate that neuroendocrine and ovarian deficits are linked to infertility observed in Esr2-mutant rats. (Endocrinology 158: 2330-2343, 2017) E strogen signaling plays an important regulatory role in the development and function of the reproductive system (1). Two nuclear receptors, estrogen receptor a [also called estrogen receptor 1 (ESR1)] and estrogen receptor b [also called estrogen receptor 2 (ESR2)] transduce cellular responses to estrogens (2) (3) (4) (5) . Studies with estrogen-receptor-mutant models have significantly advanced our understanding of the physiology of estrogen action. In the mouse and rat, disruption of Esr1 causes infertility in both males and females (6) (7) (8) .
However, the effects of Esr2 gene disruption in the mouse range from subfertility to unexplained infertility in both males and females (7, (9) (10) (11) (12) . Such variability can be related to differences in the sites targeted for mutagenesis and potential inframe alternative splicing of Esr2 transcripts (11) .
The first Esr2 knockout mouse model was created by interrupting the DNA binding domain (DBD) with a neomycin resistance cassette (9) . In this model, mutant females were subfertile and mice exhibited abnormalities in the brain, prostate, lung, colon, and immune system (12) (13) (14) (15) (16) (17) . A separate research group used a similar targeting approach to make an Esr2 knockout mouse exhibiting reproductive phenotypes, ranging from female subfertility to infertility (7). Shughrue et al. (10, 18) generated another Esr2-mutant mouse model by insertion of stop codons at the 19th codon and placement of a neomycin resistance gene in the reverse orientation, and used the model to investigate the involvement of ESR2 in estrogen action within the brain. Unlike Esr1 mutants, males were fertile in each of these three Esr2-mutant models. Subsequent mutant Esr2 mouse models were generated through Cre/LoxP-mediated targeted deletion of exon 3 (11, 12) . Antal et al. (11) observed female and male infertility, whereas Maneix et al. (12) reported only female infertility due to a failure of ovulation. Because of these variations in findings among independently generated mutant Esr2 mouse models, the physiological role of ESR2 remains controversial (11, 12, 19) .
ESR1 and ESR2 can regulate biological functions through direct DNA binding to a motif referred to as the estrogen response element (ERE), where they act to regulate gene transcription (20) . Alternatively, ESR1 and ESR2 can also influence gene transcription through tethering to transcription factors such as activator protein 1, specificity protein 1, or nuclear factor kappa B, and, thus, act independently of an ERE (21) (22) (23) . Exon 3 of Esr2, which encodes part of the DBD, was the site for mutagenesis in each of the mouse models generated to interfere with ESR2 function (7, (9) (10) (11) (12) . Maneix et al. (12) have proposed that the wide range of phenotypes associated with mutant Esr2 mouse models was attributed to variable impacts of the mutations on non-ERE-dependent functions.
To date, the mouse has dominated genetic approaches to reproductive biology research (24) , including the study of estrogen action (1, 25) . The advent of genome editing strategies has expanded the range of animal models available for genetic research (26, 27) . The rat has a rich history as a model for mammalian reproduction and is especially amenable to investigations on the endocrine regulation of female fertility (28) (29) (30) . Recently, mutant rat models have been established for investigating both estrogen and progesterone action in female reproductive function (8, 31) .
In this report, we generated two new mutant rat models to investigate the physiological role of ESR2 and to distinguish ERE-dependent function of ESR2 from non-ERE-dependent actions. Using zinc finger nuclease (ZFN)-mediated genome editing, we deleted exon 3 (DE3) in one model, and exon 4 (DE4) in a second. Deletion of exon 3 resulted in a frameshift and a null mutation, whereas deletion of exon 4 generated an allele that expressed an ESR2 protein lacking a functional DBD.
In both mutant models, males were fertile, whereas females were infertile due to a failure in ovulation.
Materials and Methods

Generation of Esr2-mutant rat models
Holtzman Sprague-Dawley rats obtained from Envigo (Indianapolis, IN) were used for the generation of targeted mutations in the Esr2 gene. The University of Kansas Medical Center Animal Care and Use Committee approved all protocols for generation of Esr2-mutant rats and their phenotypic characterization. Exon 3 was targeted to generate a frameshift and null mutation in the rat ESR2 coding sequence, and exon 4 was targeted to generate an inframe mutation resulting in an ESR2 protein lacking part of the DBD. Targeted mutations were generated by ZFN-mediated genome editing. ZFN constructs specific for exon 3 or exon 4 of rat Esr2 were designed, assembled, and validated by Sigma-Aldrich (St. Louis, MO). Selected ZFNs were targeted to exon 3 (TGCTCACTTCTGCCCCGTCtgcagcGATTATGCATCT-GGG; nucleotides: 1309-1348, XM_006240221.3) or to exon 4 (CAGGCCTGCCGACTTCGCAagtgtTATGAAGTAG-GAATGGTC; nucleotides 1478-1519, XM_006240221.3). In vitro-transcribed ZFN mRNAs were microinjected into singlecell-stage rat embryos. Injected embryos were transferred to the oviduct of day 0.5 pseudopregnant rats and offspring were screened for targeted Esr2 mutations.
Identification of founders and establishment of Esr2-mutant rat strains
Genotyping was performed by polymerase chain reaction (PCR) on genomic DNA samples extracted from tail-tip biopsy specimens, using the RED Extract-N-Amp tissue PCR kit (Sigma-Aldrich) and primers targeting flanking intron sequences. Stepwise increases in the target region flanking the ZFN site (500 bp to 5 kbp) were PCR amplified to assess possible deletions. PCR products were identified by agarose gel electrophoresis and ethidium bromide staining, and the specific sites of mutations were determined by DNA sequencing. Among the multiple founders possessing mutations in exon 3 or exon 4 (Supplemental Tables 1 and 2 
Esr2-mutant RNA analyses and expression constructs
Mutant Esr2 mRNAs were detected by reverse transcription-PCR (RT-PCR) using primers within exons flanking the targeted exons 3 and 4 (Supplemental Table 5 ). Changes in open reading frames of transcripts were determined by DNA sequencing. Full-length Esr2 cDNA was cloned into pCMV-SC expression vectors (StrataClone Mammalian Expression System, Agilent Technologies, Santa Clara, CA), and DE3 and DE4 mutations were generated by PCR-based site-directed mutagenesis. Additionally, WT, Esr2 DE3 -, and Esr2 DE4 -mutant cDNAs were PCR amplified using primers shown in Supplemental Table 6 and cloned into expression vectors with or without C-terminal FLAG tags (Agilent Technologies). Expression vectors were transfected into 293FT cells (Thermo Fisher Scientific, Carlsbad, CA), using Lipofectamine 2000 (Thermo Fisher Scientific) and recombinant proteins analyzed. A rabbit monoclonal antibody directed to amino acids 63 through 82 of rat ESR2 (clone 68-4; catalog no. 05-824; Research Resource Identifier: AB_11212759; EMD Millipore, Billerica, MA) was used for immunodetection. Flag-tagged proteins were detected using a mouse monoclonal anti-FLAG antibody (A00187; Research Resource Identifier: AB_1720813; GenScript, Piscataway, NJ).
ESR2 transactivation
To assess the ERE-binding and transcriptional activation function of the DE4 mutant, ERE-dependent luciferase activity was assessed by cotransfection of WT or DE4 ESR2 expression vectors with an ERE-reporter vector (3XERE-TATA-Luc construct, No. 11354; Addgene, Cambridge, MA) into HeLa cells (American Type Culture Collection, Manassas, VA) or an AP1-reporter vector (5XTRE-TATA-luc) into MCF7 cells (American Type Culture Collection) using Lipofectamine 2000 (Thermo Fisher Scientific). A Renilla vector (pGL4.74[hRluc/ TK]) was used as an internal control. Twenty-four hours after transfection, cells were stimulated with 10 nM 17b estradiol (E2) or 5 mM tamoxifen (Sigma-Aldrich) for an additional 24 hours. Standard dual-luciferase assays were performed on the cell lysates, using dual-luciferase reporter assay reagents (Promega, Madison, WI).
Phenotypic characterization
The reproductive phenotypes of WT and mutant rats were examined. The onset of puberty was monitored in males by preputial separation (32) and in females by vaginal opening (33) . After vaginal opening, vaginal lavages were performed daily and cytology examined microscopically to determine reproductive cyclicity. At 8 to 12 weeks of age, female rats were weighed and killed at key phases of the estrous cycle (34, 35) . Blood samples were obtained by cardiac puncture. At 12 to 16 weeks of age, male rats were weighed and killed. Ovaries, uteri, and mammary glands were collected from females, whereas testes, epididymides, and seminal vesicles were recovered from males. Each organ was weighed and fixed in 4% paraformaldehyde or snap-frozen in liquid nitrogen and stored at 280°C until processed for RNA or protein analyses. Histological examinations for all tissues were performed on paraffin-embedded, hematoxylin-and-eosin-stained sections.
Fertility tests
Fertility was assessed by cohabiting 12-to 16-week-old male rats with 8-to 12-week-old female rats for 12 weeks and recording pregnancies and litter sizes. The breeding combinations included WT males with WT or homozygous Esr2-mutant females and homozygous Esr2-mutant males with WT females. Vaginal cytology was monitored daily to record estrous cyclicity, mating (presence of sperm), signs of pregnancy (continuous diestrus), and litter size.
Uterine responses to E2
Four-week-old WT and age-matched Esr2-mutant female rats were tested for uterine responsiveness to E2. E2 (40 mg/kg) or vehicle (sesame oil) was injected subcutaneously for three consecutive days and uteri collected for measurement of gravimetric responses.
Ovulatory responses to exogenous gonadotropins
At 4 weeks of age, female rats were tested for responsiveness to exogenous gonadotropins (31, 33) . Females were treated intraperitoneally with 30 IU of equine chorionic gonadotropin (eCG) at 1500 hours; 48 hours later, 30 IU of human chorionic gonadotropin (hCG) was injected.
At 24 hours after the hCG injection, animals were killed, oocytes were recovered from the oviduct, cumulus cells removed using hyaluronidase (Sigma-Aldrich), and oocytes counted. In additional experiments, rats were killed at 4, 10, and 24 hours after the hCG injection, and ovaries and oviducts were collected, weighed, processed for histology, or snap frozen for subsequent RNA or protein analyses. Total RNA was reverse-transcribed using the high-capacity reverse transcription kit (Thermo Fisher Scientific) and expression of target genes (Supplemental Table 7 ) was evaluated by quantitative PCR. Primer sequences used in the analyses are shown in Supplemental Table 7 .
Hormone measurements
Blood samples were collected at 0800 hours during day 1 of diestrus, proestrus, and estrus, and also at 2000 hours on proestrus, which coincides with the preovulatory surge of luteinizing hormone (LH) (34, 35) . Serum LH and follicle-stimulating hormone concentrations were determined by Milliplex MAP kits (EMD Millipore). Serum E2 concentrations were measured by radioimmunoassay, as previously described (36) .
Statistical analysis
Statistical analyses were performed using the SPSS Statistical Package (IBM, Armonk, NY). Comparisons of two means were analyzed by Student t test, whereas multiple comparisons were analyzed by analysis of variance followed by Tukey test, using GraphPad prism software (GraphPad Software, La Jolla, CA).
Results
In vitro evaluation of ESR2 transcripts and proteins
Targeted exon deletion in the rat Esr2 gene was simulated and analyzed for predicted translation products (Fig. 1) . Deletion of exon 3 caused loss of ESR2 expression due to an out-of-frame translation product generating a premature stop codon [ Fig. 1(b) ]. In contrast, deletion of exon 4 resulted in an inframe mutation generating a mutant ESR2 protein that lacks an intact DBD [ Fig. 1(c) ]. cDNAs with targeted deletion of exons 3 or 4 were subsequently cloned into expression vectors and transfected into 293FT cells to evaluate expression of these mutant proteins. This in vitro expression experiment verified the predicted translation products [ Fig. 1(d) and 1(e) ]. ESR2 protein was not detected from the DE3 expression construct [ Fig.  1(d) ]; however, a mutant protein with slightly lower molecular weight was detected from the DE4 expression https://academic.oup.com/endoconstruct [ Fig. 1(e) ]. The absence of ERE binding-dependent transcriptional activity of the exon 4 deletion construct was also confirmed [ Fig. 1(f) ]. Both WT and DE4 ESR2 were capable of transactivation of an AP1 responsive reporter to a similar level [ Fig. 1(g) ].
Generation of Esr2-mutant rats On the basis of the in vitro evaluation of the ESR2 transcripts and proteins, mRNAs encoding ZFNs targeting exon 3 or exon 4 [ Fig. 2(a) ] were generated and microinjected into single-cell embryos to produce mutant rats. Multiple founders with targeted exon 3 or exon 4 deletions were identified (Supplemental Tables 1 and 2 Expression of ESR2 in Esr2 DE3 -and Esr2 DE4 -mutant rat models The DE3 and DE4 deletion mutations were analyzed at both the mRNA and protein levels using ovarian tissue DE4 -mutant ovaries to detect DE4-mutant transcripts. Sequencing of the RT-PCR products indicated that (f) ZFN-edited DE4-mutant transcript is indistinguishable from (g) the naturally occurring endogenous DE4 isoform. Western blot analyses of granulosa cell proteins demonstrated undetectable ESR2 protein in (h) DE3-mutant ovaries and (i) a truncated ESR2 protein in DE4-mutant ovaries. (j, k) Full-length WT and mutant ESR2 coding sequences were amplified by RT-PCR, cloned into a mammalian expression vector with a C-terminal FLAG-tag, and expressed in 293FT cells. Western blot analysis with anti-FLAG antibody did not detect expression of (j) recombinant DE3 ESR2 protein but detected (k) a truncated DE4 ESR2 protein.
samples (Fig. 2) . Sequencing of RT-PCR products indicated that two different DE3-mutant transcripts were generated from alternative splicing between exons 2 and 4 or exons 2 and 5 [ Fig. 2(b-d) ]. Splicing between exons 2 and 4 was predominant and generated a frameshift with two premature stop codons after amino acid 140 [ Fig. 2(c) ]. Splicing between exons 2 to 5 also generated a frameshift 17 aberrant codons after amino acid 140 followed by a premature stop codon [ Fig. 2(d)] .
Deletion of exon 4 resulted in exclusive splicing between exons 3 and 5 of Esr2 [ Fig. 2(e-g) Western blot analyses confirmed the absence of ESR2 protein in Esr2
DE3
-mutant ovaries [ Fig. 2(h) ], whereas a truncated ESR2 protein was detected in Esr2 DE4 ovaries [ Fig. 2(i) ]. To examine whether the DE3 or DE4 mutations caused any alternative or aberrant transcription or translation, we also cloned full-length mutant and WT Esr2 mRNAs into expression vectors, and sequenced and verified their expression using carboxy-terminal FLAG tags in 293FT cells. These in vitro expression studies confirmed the predicted translational processing of Esr2
-and Esr2
DE4
-mutant mRNAs [ Fig. 2 (j) and 2(k)]. 
(d) Both Esr2
DE3 -and Esr2 DE4 -mutant males were fertile and their fertility was comparable to that of WT males. However, Esr2 DE3 -and Esr2 DE4 -mutant females did not become pregnant (n $ 12 in each group). (e-g) Vaginal cytology of adult (8-12 weeks old) Esr2 DE3 -and Esr2 DE4 -mutant females showed cyclic changes similar to WT female rats. When mutant females cohabitated with WT males, they mated but did not become pregnant or pseudopregnant. (h-j) Changes in serum hormone levels during specific stages of the estrous cycle were examined in WT vs Esr2 DE3 -and Esr2 DE4 -mutant females. Samples were collected at 0800 hours on the morning of proestrus (Pm), 2000 hours on the evening of proestrus (Pe), and 0800 hours on the morning of estrus (Em), and the first day of diestrus (Dm; n = 6 on collection day).
Results are presented as mean 6 standard error of the mean. Asterisks indicate significant differences between Esr2 mutant and WT means (P , 0.05). Serum E2, LH, and follicle-stimulating hormone (FSH) concentrations were measured. Serum E2 concentrations were significantly lower during proestrus in Esr2-mutant rats vs WT control rats. In addition, LH and FSH levels during the evening of proestrus were significantly lower in Esr2 DE3 -and Esr2 DE4 -mutant female rats vs WT control rats. D, diestrus; E, estrus; P, proestrus. Reproductive tract in Esr2-mutant rat models The size and histological organization of testes, epididymides, and seminal vesicles in Esr2 DE3 -and Esr2 DE4 -mutant males were similar to those of WT males (Fig. 4) . Ovaries in Esr2 DE3 -and Esr2 DE4 -mutant rats were smaller than those from WT controls [ Fig. 5(a-c) ].
Ovaries from both of the mutant groups, as well as WT controls, contained follicles in various stages of development. In contrast, there was no evidence of corpora lutea in ovaries from Esr2 DE3 or Esr2 Ovulatory responses to gonadotropin treatment in Esr2-mutant rat models The absence of corpora lutea in Esr2 DE3 -and Esr2 DE4 -mutant ovaries prompted an assessment of the regulation of ovulation in the mutant females. Four-week-old Esr2-mutant females and their WT littermates were treated with gonadotropins, and ovarian weights and oocyte yield were evaluated The reproductive tracts of adult WT and Esr2 DE3 -and Esr2 DE4 -mutant males (12 to 14 weeks of age) were examined, including gross appearance and weights for (a-c) testes, (d-f) epididymides, and (g-i) seminal vesicles. Sample sizes for the organ weight measurements were $10 per genotype. Representative hematoxylin and eosin-stained tissue sections of (j-l) testis, (m-o) caput epididymis, and (p-r) cauda epididymis from WT and Esr2 DE3 -and Esr2 DE4 -mutant male rats are presented. No significant differences in reproductive tracts were observed between the WT and Esr2-mutant male rats. Scale bars, 500 mM. Epid, epididymis; SV, seminal vesicle; wt., weight. DE3 -and (b, c) Esr2 DE4 -mutant rats were smaller than those of WT rats (n = 6). Histological examination of hematoxylin and eosin (H&E)-stained ovary sections shows the presence of (d, g) multiple corpora lutea in WT ovaries, whereas (e, h) Esr2 DE3 -or (f, i) Esr2 DE4 -mutant ovaries were characterized by the absence of corpora lutea despite presence of numerous follicles in various stages of development. [Boxed areas of (d-f) are magnified in (g-i).] Uteri of (j, l) Esr2 DE3 -and (k, l) Esr2 DE4 -mutant rats were smaller than those of WT rats (n = 6). H&E-stained uterine sections show that (n) Esr2 DE3 -and (o) Esr2 DE4 -mutant uteri possessed all three definitive uterine compartments: myometrium, endometrial stroma, and epithelium; however, all were relatively smaller than that found in (m) the WT uterine sections. Scale bars, 1000 mM (d-f and m-o) and 100 mM (g-i). Results are presented as mean 6 standard error of the mean. Asterisks indicate significant differences between Esr2 mutant and WT means (P , 0.05). a, antrum; cl, corpus luteum; gr, granulosa layer; o, oocyte; wt, weight. [ Fig. 6(a) ]. Gonadotropin treatment stimulated ovarian weight in WT females and, to a lesser extent, in Esr2-mutant females [ Fig. 6(b) ]. Gonadotropins triggered ovulation and the presence of oocytes in oviducts of WT females but not in Esr2
DE3
DE4
-mutant females [ Fig. 6(c) ]. Upon histological examination, Esr2-mutant ovaries exhibited many antral follicles containing trapped oocytes and an absence of corpora lutea, indicating a failure in ovulatory responses to gonadotropins compared with WT ovaries [ Fig. 6(d-i) ].
Next, we investigated the expression of genes known to be involved in the control of follicle rupture after gonadotropin stimulation (38) (39) (40) (Fig. 7) . Unlike WT females, exogenous gonadotropin treatment failed to upregulate the expression of transcriptional regulators Pgr, Arnt2, and Runx2 [ Fig. 7(b-d) ], enzymes involved in the biosynthesis of prostaglandins, proteolysis, and protection from oxidative stress [Ptgs2, Adamts1, Hpgd, and Srxn1; Fig. 7(e-h) ], and protein kinase stabilizers such as Fam110c and Akap12 [ Fig. 7(i) and 7(j) ]. In contrast, the transcriptional regulators Trim61 and Pou5f1 were uniquely upregulated in ovaries from gonadotropintreated Esr2 mutant rats [ Fig. 7(k-m) ]. Other transcripts exhibited distinct profiles in ovaries of WT and Esr2-mutant rats treated with gonadotropins, including Fshr, Lhcgr, Klf4, Cyp11a1, Abcb1b, and Scube1 (Supplemental Fig. 4) . The significance of these latter changes in gonadotropin-dependent transcript responses remains to be determined.
Our findings that both Esr2 DE3 -and Esr2 DE4 -mutant females exhibited failed ovulation, and of the absence of corpora lutea and aberrant ovarian gene expression indicated that the DBD/ERE-dependent function of ESR2 is essential for gonadotropin-mediated ovarian responses, including ovulation.
Discussion
The physiological role of ESR2 in reproductive function remains controversial, mainly due to a wide variation in phenotypic observations among an assortment of DE3 -and Esr2 DE4 -mutant rats did not ovulate after eCG and hCG treatment (n = 10 per group). Histological examination of hematoxylin and eosin-stained ovary sections revealed that (d, g) WT ovaries contained follicles at various stages of maturation and corpora lutea, whereas (e, h) Esr2
DE3
-or (f, i) Esr2 DE4 -mutant ovaries exhibited numerous follicles and the absence of corpora lutea. *P , 0.05. Scale bars, 1000 mM (d-f) and 100 mM (g-i). Sac, sacrifice.
different mutant mouse models (7, (9) (10) (11) (12) . The variability in mutant phenotypes is associated with selection of distinct gene-targeting sites and methods for mutagenesis (11) . The mechanism of ESR2 action may also be a confounding factor for such phenotypic variability (12) . The estrogen-ESR2 complex can bind directly to an ERE or can tether to other transcription factors (41) (42) (43) , facilitating interactions with appropriate coregulators to activate or repress its target genes (44) (45) (46) (47) . In this study, we explored the role of ESR2 in reproductive Figure 7 . Gonadotropin-induced ovarian transcript responses in Esr2-mutant rats. RNA was extracted from gonadotropin-stimulated ovaries and expression of potential ESR2 target genes was examined by quantitative RT-PCR. (a) Four-week old WT and Esr2-mutant female rats were treated with eCG and hCG as indicated. Animals were euthanized and ovaries harvested from untreated animals (basal) 48 hours after eCG administration (eCG 48h) and 4 hours after hCG administration (hCG 4h). (b-j) WT ovaries responded with an upregulation of (b) Pgr, (c) Arnt2, (d) Runx2, (e) Ptgs2, (f) Adamts1, (g) Hpgd, (h) Srxn1, (i) Fam110c, and (j) Akap12. (k, l) However, DE3-and DE4-mutant ovaries did not respond to the gonadotropin treatment. In contrast, expression of (k) Trim61 and (l) Pou5f1 was uniquely upregulated in gonadotropin-treated Esr2-mutant ovaries. (m) Ahr expression remained unchanged after gonadotropin treatment. Results are expressed as mean 6 standard error of the mean of gonadotropin-induced fold changes relative to basal levels (n = 4 per group). Asterisks indicate significant differences between Esr2-mutant and WT means (P , 0.05). eCG, equine chorionic gonadotropin; Rel exp, relative expression. ). It is important to point out that deletion of exon 4 in the Esr2 DE4 model also corresponds to a naturally occurring splice variant identified in both rodent (37) and human tissues (48, 49) . In contrast to the collective analysis of Esr2-mutant mouse models (7, (9) (10) (11) (12) , our findings with these two mutant ESR2 rat models were unequivocal. Disruption of ESR2 was compatible with fertility in male rats, whereas both ESR2 null and DBD mutations interfered with female fertility because of deficits in ovarian function. Infertility in ESR2-mutant rats and subfertility in ESR2-mutant mice are associated with disrupted ovarian production of estrogen (39, 50, 51) . Ovarian granulosa cells express ESR2 (52, 53) . Loss of ESR2 leads to diminished granulosa cell responsiveness to gonadotropins and impairments in follicle maturation (39, 40, 50, 51) . In addition, disruption of ESR2 appears to negatively impact gonadotropin-driven intracellular signaling pathways within granulosa cells (54, 55) . The Esr2 DE3 and Esr2 DE4 rat models represent new tools for dissecting the mechanism of ESR2 action within granulosa cells. Unlike ESR2-mutant mice, ESR2-mutant rats did not ovulate when two different doses of gonadotropins were administered. This suggests that ESR2 plays an essential role in regulating preovulatory follicular maturation and ovulation in the rat. This was further exemplified by the aberrant expression of several key genes involved in ovarian/granulosa cell function in ESR2-mutant rats.
Changes in expression pattern were similar in both the ESR2-mutant groups; therefore, DNA-binding dependent transcriptional function appears critical for regulation of these genes. Whether this is strictly due to disruption of the estrogen-signaling cascade within the ovary or a developmental anomaly associated with loss of ESR2 is currently unknown.
An attenuated preovulatory gonadotropin surge was identified in ESR2-mutant rats, similar to previous observations in ESR2-mutant mice (56) . ESR2 has been implicated in neuroendocrine regulation. The ESR2 protein is present in the rat anterior pituitary and throughout the brain, including areas responsible for regulating gonadotropin-releasing hormone synthesis and secretion (57) (58) (59) (60) (61) . Furthermore, neuronal disruption of ESR2 has been reported to delay puberty through alterations in kisspeptin expression (62) . However, a hypothalamohypophyseal site of ESR2 action is not critical for regulation of preovulatory gonadotropin secretion. Korach et al. (56) , through a series of ovary transplantation experiments, have implicated the ovary and diminished preovulatory estrogen secretion for dysregulated gonadotropin secretion in the ESR2-mutant female mouse. Whether ovarian ESR2 serves a similar role in regulating the preovulatory gonadotropin surge in the rat remains to be determined.
Naturally occurring isoforms of ESR2 arising from alternative splicing are present in rodents and humans (37, 48, (63) (64) (65) (66) . The DE4 ESR2 protein variant is present in numerous tissues (37) . This ESR2 variant can bind estradiol (37) and function through a non-ERE pathway (12 may be involved in fine-tuning reproductive function or contributing to the regulation of non-ERE-mediated pathways in other physiological processes.
In conclusion, phenotypic characterization of the mutant Esr2 DE3 and Esr2 DE4 rat models has resolved uncertainties regarding ESR2 action and led to the following insights: (1) ESR2 is not critical for the regulation of male fertility; (2) ESR2 is an essential regulator of female fertility; (3) ESR2 contributes to the regulation of the preovulatory gonadotropin surge; (4) ESR2 is essential for gonadotropin-regulated ovulatory events; and (5) the role of ESR2 in the regulation of female fertility depends on ESR2 acting in trans through binding to ERE motifs.
